BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mottram L, Chakraborty S, Cox E, Fleckenstein J. How genomics can be used to understand host susceptibility to enteric infection, aiding in the development of vaccines and immunotherapeutic interventions. Vaccine 2019;37:4805-10. [PMID: 30709726 DOI: 10.1016/j.vaccine.2019.01.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Kuhlmann FM, Laine RO, Afrin S, Nakajima R, Akhtar M, Vickers T, Parker K, Nizam NN, Grigura V, Goss CW, Felgner PL, Rasko DA, Qadri F, Fleckenstein JM. Contribution of Noncanonical Antigens to Virulence and Adaptive Immunity in Human Infection with Enterotoxigenic E. coli. Infect Immun 2021;89:e00041-21. [PMID: 33558320 DOI: 10.1128/IAI.00041-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Celis-Giraldo CT, López-Abán J, Muro A, Patarroyo MA, Manzano-Román R. Nanovaccines against Animal Pathogens: The Latest Findings. Vaccines (Basel) 2021;9:988. [PMID: 34579225 DOI: 10.3390/vaccines9090988] [Reference Citation Analysis]
3 Mottram L, Lundgren A, Svennerholm AM, Leach S. A Systems Biology Approach Identifies B Cell Maturation Antigen (BCMA) as a Biomarker Reflecting Oral Vaccine Induced IgA Antibody Responses in Humans. Front Immunol 2021;12:647873. [PMID: 33828557 DOI: 10.3389/fimmu.2021.647873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Oli AN, Obialor WO, Ifeanyichukwu MO, Odimegwu DC, Okoyeh JN, Emechebe GO, Adejumo SA, Ibeanu GC. Immunoinformatics and Vaccine Development: An Overview. Immunotargets Ther 2020;9:13-30. [PMID: 32161726 DOI: 10.2147/ITT.S241064] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
5 Keddy KH, Saha S, Okeke IN, Kalule JB, Qamar FN, Kariuki S. TEMPORARY REMOVAL: Big data, biomarkers and proteomics: Informing childhood diarrhoeal disease management in low- and middle-income countries. EBioMedicine 2021;73:103668. [PMID: 34742129 DOI: 10.1016/j.ebiom.2021.103668] [Reference Citation Analysis]
6 Santos-Cortez RLP, Ehrlich GD, Ryan AF. Editorial: Otitis Media Genomics and the Middle Ear Microbiome. Front Genet 2021;12:763688. [PMID: 34712274 DOI: 10.3389/fgene.2021.763688] [Reference Citation Analysis]
7 Fleckenstein JM. Confronting Challenges to Enterotoxigenic Escherichia coli Vaccine Development. Front Trop Dis 2021;2:709907. [DOI: 10.3389/fitd.2021.709907] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]